Claim benefit due to a statistically significant primary endpoint and ignored one or more statistically nonsignificant primary endpoints | 18 (32) |
Claim benefit based on a statistically significant secondary endpoint | 15 (26) |
Claim equivalence/non-inferiority versus comparator for a statistically nonsignificant endpoint | 11 (19) |
Focus on another objective (eg, trial is statistically nonsignificant but they say they accomplish some goal that they did not prespecify) | 7 (12) |
Claim benefit based on statistically significant subgroup analysis | 3 (5) |
Claim benefit based on statistically significant modified treatment population (eg, per-protocol instead of intention to treat) | 1 (2) |
Claim benefit based on statistically significant within group analysis | 1 (2) |
Emphasise on the magnitude of difference in the presence of a statistically nonsignificant p value | 1 (2) |